Tahir Misbah bought MAZE
March 2, 2026 · Form 4 insider transaction
Tahir Misbah bought 40,000 shares of Maze Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
40,000
Price
$0.00
Total value
N/A
InsiderTahir Misbah
RoleOfficer
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateMarch 2, 2026
Filing dateMarch 3, 2026
Shares owned after40,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The option award shall vest as to 1/48 of the total award monthly, with the first tranche vesting on April 1, 2026, subject to the reporting person's continued service to the Issuer on each vesting date.